Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $115.63 | $24.01 | 381.50% | 218.17x | 55.03x | 14.67x | 17.71x | 1.58x | $106.92M | 0.88% | $705.78M | 6.70 | $12.40B | 1,580.34 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $27.33 | $8.20 | 233.12% | 130.14x | 61.10x | 7.69x | 15.57x | 1.11x | $39.15M | 1.10% | $220.58M | 1.69 | $3.51B | 77.43 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $76.10 | $17.30 | 339.85% | 71.12x | 65.10x | 7.02x | 9.08x | 1.82x | $182.84M | 3.10% | $654.15M | 8.43 | $5.77B | 48.11 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $255.36 | $80.38 | 217.69% | 41.86x | 37.87x | 7.10x | 25.23x | 1.44x | $793.95M | 2.33% | $1.35B | 10.14 | $35.45B | 30.06 | ||
| KRYS | KRYSTAL BIOTECH INC | $337.08 | $83.87 | 301.89% | 40.76x | 43.18x | 22.60x | 7.34x | 2.18x | $257.78M | 2.59% | $1.36B | 46.03 | $9.56B | 40.97 | ||
| VCEL | VERICEL CORP | $40.24 | $7.99 | 403.86% | 83.83x | 71.90x | 6.71x | 5.57x | 2.06x | $61.66M | 3.00% | $370.04M | 7.25 | $2.03B | 46.04 | ||
| RPRX | ROYALTY PHARMA PLC | $58.37 | $36.14 | 61.51% | 31.05x | 10.67x | 10.24x | 3.43x | 0.63x | $2.92B | 11.25% | $9.79B | 21.99 | $41.71B | 35.47 | ||
| HALO | HALOZYME THERAPEUTICS INC | $112.89 | $71.08 | 58.81% | 31.71x | 12.50x | 7.96x | 89.26x | 0.61x | $806.22M | 6.09% | $143.54M | 1.22 | $14.80B | 20.59 | ||
| TGTX | TG THERAPEUTICS INC | $56.19 | $22.40 | 150.90% | 18.24x | 56.54x | 9.96x | 14.24x | 2.03x | $17.39M | 0.22% | $604.08M | 4.26 | $8.87B | 63.71 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $11.30 | $7.60 | 48.63% | 11.89x | 10.39x | 4.91x | 3.08x | 1.04x | $82.01M | 12.27% | $217.65M | 3.68 | $527.21M | 6.82 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.46 | $18.61 | 219.42% | 156.47x | 20.55x | 3.38x | 1.82x | 1.04x | $738.18M | 6.42% | $6.32B | 32.68 | $14.82B | 38.43 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $314.10 | $85.76 | 266.25% | 31.19x | 33.25x | 21.69x | 6.47x | 2.36x | $130.62M | 2.07% | $967.52M | 48.22 | $6.39B | 22.89 | ||
| MDXG | MIMEDX GROUP INC | $4.68 | $1.27 | 267.98% | 117.00x | -26.99x | 1.95x | 3.16x | 1.27x | $44.50M | 6.43% | $216.00M | 1.46 | $563.53M | 24.71 | ||
| EXEL | EXELIXIS INC | $58.37 | $29.97 | 94.74% | 17.74x | 17.64x | 6.01x | 7.84x | 1.17x | $1.17B | 8.01% | $1.84B | 7.35 | $14.35B | 13.19 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $238.28 | $180.08 | 32.32% | 15.61x | 9.32x | 3.27x | 3.22x | 0.64x | $1.62B | 10.75% | $4.80B | 75.98 | $18.24B | 11.29 | ||
| ADMA | ADMA BIOLOGICS INC | $10.12 | $6.97 | 45.18% | 14.06x | 12.72x | 4.51x | 5.55x | 0.82x | $116.47M | 5.04% | $408.21M | 1.79 | $2.33B | 9.99 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $527.67 | $148.21 | 256.02% | 30.45x | 27.56x | 10.64x | 6.61x | 2.29x | $3.80B | 2.84% | $20.25B | 79.81 | $129.58B | 23.55 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $40.01 | $30.06 | 33.09% | 12.74x | 9.60x | 2.41x | 2.33x | 0.76x | $354.90M | 15.31% | $999.24M | 17.25 | $1.93B | 6.91 | ||
| UTHR | UNITED THERAPEUTICS CORP | $485.54 | $188.43 | 157.68% | 16.06x | 18.17x | 6.56x | 3.25x | 2.94x | $1.09B | 5.28% | $6.40B | 150.24 | $19.02B | 11.35 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $752.25 | $427.47 | 75.98% | 17.94x | 13.41x | 4.98x | 2.44x | 0.95x | $3.76B | 4.86% | $31.71B | 308.48 | $77.70B | 13.51 | ||
| TECH | BIO-TECHNE CORP | $72.51 | $16.27 | 345.76% | 61.97x | 34.90x | 9.31x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.40B | 32.78 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.19 | $1.39 | -14.18% | 8.50x | -2.68x | 1.47x | 1.57x | 0.47x | $19.58M | 28.40% | $44.20M | 0.76 | $20.57M | 2.69 | ||
| VCYT | VERACYTE INC | $45.23 | $11.72 | 286.07% | 31.41x | 23.26x | 6.44x | 2.62x | 2.64x | $165.99M | 4.59% | $1.39B | 17.36 | $3.37B | 24.16 | ||
| INCY | INCYTE CORP | $124.82 | $58.85 | 112.11% | 15.37x | 35.21x | 4.30x | 3.99x | 1.73x | $1.92B | 7.68% | $6.34B | 31.66 | $21.35B | 10.32 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.